BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12107769)

  • 21. [Remarkable response of simultaneous advanced esophageal and gastric cancer to combined chemotherapy with weekday-on/Weekend-off TS-1 plus biweekly cisplatin].
    Wakabayashi K; Hayashi S; Masuda H; Karube H; Ookame H; Aoki H; Sakamoto N; Fujii M; Takayama T
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1337-42. PubMed ID: 14518417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of the histoculture drug response assay (HDRA) based perioperative chemotherapy for non-small cell lung cancer].
    Tanahashi M; Yamada T; Moriyama S; Suzuki E; Niwa H
    Kyobu Geka; 2008 Jan; 61(1):26-30. PubMed ID: 18186269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preoperative chemoradiation in esophageal cancer: experience of a single center in 102 patients].
    Imdahl A; Schöffel U; Ruf G; Hopf UT
    Zentralbl Chir; 2004 Oct; 129(5):350-5. PubMed ID: 15486784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase II study of sequential methotrexate and 5-fluorouracil chemotherapy in previously treated gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group, JCOG 9207 trial.
    Hamaguchi T; Shirao K; Yamamichi N; Hyodo I; Koizumi W; Seki S; Imamura T; Honma H; Ohtsu A; Boku N; Mukai T; Yamamoto S; Fukuda H; Yoshida S;
    Jpn J Clin Oncol; 2008 Jun; 38(6):432-7. PubMed ID: 18515821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
    Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
    Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro histoculture drug response assay and in vivo blood chemistry of a novel Pt(IV) compound, K104.
    Kwon YE; Park JY; Kim WK
    Anticancer Res; 2007; 27(1A):321-6. PubMed ID: 17352249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of distant metastases in patients with oesophageal or gastric cardia cancer: a diagnostic decision analysis.
    van Vliet EP; Steyerberg EW; Eijkemans MJ; Kuipers EJ; Siersema PD
    Br J Cancer; 2007 Oct; 97(7):868-76. PubMed ID: 17848957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Progress of individualized chemotherapy guided by chemosensitivity test].
    Mi YJ; Zhang CZ; Fu LW
    Yao Xue Xue Bao; 2009 Nov; 44(11):1187-92. PubMed ID: 21355317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new chemosensitivity assay for ascites tumor cells using a thermoreversible gelation polymer as a culture medium and the observed clinical responses.
    Isogai A; Nagaya M; Matsuoka H; Watanabe T; Tsukikawa S; Kubota S
    Eur Surg Res; 2007; 39(1):41-50. PubMed ID: 17213726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response evaluation by endoscopy, rebiopsy, and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for esophageal cancer.
    Schneider PM; Metzger R; Schaefer H; Baumgarten F; Vallbohmer D; Brabender J; Wolfgarten E; Bollschweiler E; Baldus SE; Dienes HP; Hoelscher AH
    Ann Surg; 2008 Dec; 248(6):902-8. PubMed ID: 19092334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Histoculture drug response assay guided concurrent chemoradiotherapy for non-small cell lung cancer].
    Tamaki T; Oura S; Yoshimasu T; Ota F; Nakamura R; Shimizu Y; Kiyoi M; Naito K; Hirai Y; Okamura Y
    Kyobu Geka; 2008 Jan; 61(1):31-5. PubMed ID: 18186270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer.
    Isogai A; Nagaya M; Matsuoka H; Watanabe T; Tsukikawa S; Kubota S
    Surgery; 2007 Nov; 142(5):741-8. PubMed ID: 17981195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical evaluation of chemosensitivity testing for patients with unresectable non-small cell lung cancer (NSCLC) using collagen gel droplet embedded culture drug sensitivity test (CD-DST).
    Kawamura M; Gika M; Abiko T; Inoue Y; Oyama T; Izumi Y; Kobayashi H; Kobayashi K
    Cancer Chemother Pharmacol; 2007 Mar; 59(4):507-13. PubMed ID: 16896928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of 99mTc-sestamibi scintigraphy in suggesting the therapeutic effect of chemotherapy against gastric cancer.
    Kawata K; Kanai M; Sasada T; Iwata S; Yamamoto N; Takabayashi A
    Clin Cancer Res; 2004 Jun; 10(11):3788-93. PubMed ID: 15173086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Correlation of the Histoculture Drug Response Assay for Head and Neck Cancer.
    Hoffman RM
    Methods Mol Biol; 2018; 1760():83-92. PubMed ID: 29572796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Correlation between ATP bioluminescence tumor chemosensitivity assay and clinical response in ovarian cancer].
    Tian HM; Shi XY; Fu J; Chao DY; Zhang K; Wu LY; Wang JW; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):296-8. PubMed ID: 15996325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of 5-fluorouracil applicability by multi-point collagen gel droplet embedded drug sensitivity test.
    Ochiai T; Nishimura K; Noguchi H; Kitajima M; Tsuruoka Y; Takahashi Y
    Oncol Rep; 2005 Jul; 14(1):201-5. PubMed ID: 15944790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy.
    Kinoshita M; Kodera Y; Hibi K; Nakayama G; Inoue T; Ohashi N; Ito Y; Koike M; Fujiwara M; Nakao A
    Anticancer Res; 2007; 27(2):851-6. PubMed ID: 17465211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A Case of advanced gastric cancer successfully treated with TS-1/low-dose CDDP as neoadjuvant chemotherapy].
    Yamada K; Sugiyama Y; Seino K; Kobori H; Ebina T; Shibata S; Kawasaki H; Sasaki M; Tanaka M
    Gan To Kagaku Ryoho; 2005 Oct; 32(10):1447-51. PubMed ID: 16227746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.